Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study Evaluating the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

NCT05716425 is registered in ClinicalTrials.gov with Zhejiang ACEA Pharmaceutical Co. Ltd. as lead sponsor.

NCT NCT05716425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05716425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study Evaluating the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
Lead sponsor
Zhejiang ACEA Pharmaceutical Co. Ltd.
Phase
Phase 3
Overall status
Completed
Start date
February 8, 2023
Completion date
July 26, 2023
Enrollment
1,218 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19